跳至主要内容
临床试验/jRCT1030210558
jRCT1030210558招募中不适用

Examination of hemodynamics of liver tumors such as hepatocellular carcinoma and hepatic parenchyma using intra-arterial contrast-enhanced ultrasonography

Toho University Ohashi Medical Center0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
50
主要终点
Adverse events

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Diagnostic Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • Based on the Evidence-based Clinical Practice Guidelines for hepatocellular carcinoma developed by the
  • Japan Society of Hepatology, the cases in which transarterial chemoembolization or hepatic arterial infusion
  • chemotherapy for hepatocellular carcinoma were selected and consent was obtained for this study.

排除标准

  • Based on the same guidelines, the cases that are not indicated for transarterial chemoembolization or hepatic arterial infusion chemotherapy for hepatocellular carcinoma and for which consent cannot be obtained for this study.
  • Excludes minors.

结局指标

主要结局

Adverse events

**Transarterial chemoembolization:** - Fever - Abdominal pain - Nausea, vomiting - Puncture bleeding - Renal disorder - Inguinal hematoma - Liver dysfunction - Liver abscess - Intratumoral hemorrhage **Intra-arterial contrast-enhanced ultrasound:** - Diarrhea - Headache - Proteinuria - Neutrocytopenia - Rash - Dry mouth - Itching - Dyspnea - Low blood pressure

次要结局

未报告次要终点

研究者

相似试验